SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Full list of Israeli high-tech layoffs in 2026

LinkedIn to shut down Israeli development center and lay off nearly all employees

China’s AI weather models are challenging the old forecasting order

OpenAI lets employees cash out $7 billion as IPO plans remain uncertain

Buzz

Most popular

Daily

Weekly

1

Israeli AI startup Decart nearing $6 billion sale, Musk’s SpaceX circling

2

Israel set to reject $4.2 billion Zim sale despite buyers’ concessions

3

Corma raises $60 million Seed to build AI designed to fight AI-powered cyberattacks

4

Talkspace co-founder Oren Frank dies at 60 after battle with cancer

5

Israel’s Iron Beam laser was hailed as a breakthrough. It still isn’t operational

Glaucoma

4 stories about Glaucoma

מיכאל בלקין מוסף

The 83-year-old who sold his invention for $466 million, and still walks to work every morning

14.08.25|Roni Dori

Michael Belkin’s journey from rooftop experiments to global glaucoma breakthroughs proves some minds never retire.

דריה להמן-בלומנטל

The Israeli startup treating the silent thief of sight

30.01.22|Yafit Ovadia

BELKIN Vision is using an automated laser procedure to tackle glaucoma, a disease that can lead to irreversible blindness

דריה למאן בלומנטל מנכ״ל ארגון בלקין לייזר

Belkin Laser announces $12.2 million raised in series B funding

21.07.20|Hagar Ravet

The company is in the midst of clinical testing of its one-second glaucoma treatment with the product expected to enter the market in two years

BioLight ביולייט איי אופטימה IOPtima

Shenzhen-listed Pharma Company to Acquire Tel Aviv-based Medtech Company IOPtima

21.11.17|Lilach Baumer

The Chengdu Kanghong Pharma Group will buy Tel Aviv-based IOPtima in four stages, the latter announced Tuesday through its parent company listed on the Tel Aviv Stock Exchange